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Traditionally,	   thin	   layer	   chromatography	   (TLC)	   has	   been	   used	   for	   the	   analysis	   of	   lipids	   isolated	  
from	  membrane	   complexes.	  Here,	  we	  describe	   a	  method	  based	  on	   the	   combination	  of	   TLC	   and	  
SDS-­‐polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  for	  the	  qualitative	  analysis	  of	  the	  protein/lipid	  
profile	   of	  membrane	   complexes	   such	   as	   those	   of	   lung	   surfactant.	   For	   this	   purpose,	   native	   lung	  
surfactant	  was	  applied	  onto	  a	  silica	  TLC	  plate	  in	  the	  form	  of	  an	  aqueous	  suspension,	  preserving	  not	  
only	   hydrophilic	   proteins	   associated	   to	   lipids,	   but	   also	   native	   protein-­‐lipid	   interactions.	   Using	  
native	   membrane	   complexes	   in	   a	   TLC	   allows	   the	   differential	   migration	   of	   lipids	   and	   their	  
separation	  from	  the	  protein	  components.	  As	  a	  result,	  (partly)	  delipidated	  protein-­‐enriched	  bands	  
can	  be	  visualized	  and	  analysed	  by	  SDS-­‐PAGE	  to	   identify	  proteins	  originally	  associated	  with	   lipids.	  
Interestingly,	   the	  hydrophobic	  surfactant	  protein	  SP-­‐C,	  which	   interact	  tightly	  with	   lipids	   in	  native	  
membrane	  complexes,	  migrate	   through	   the	  TLC	  plate	  configuring	   specific	  bands	   that	  differ	   from	  
those	  corresponding	  to	  lipids	  or	  proteins.	  This	  method	  therefore	  allows	  the	  detection	  and	  analysis	  
of	  strong	  native-­‐like	  protein-­‐lipid	  interactions.	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Thin	   layer	   chromatography	   (TLC)	   is	   a	   traditional	   technique	   typically	   used	   to	   separate	   and	   study	  
lipid	  composition	  in	  many	  biological	  tissues	  (1-­‐5)	  and	  membrane	  complexes.	  An	  example	  of	  this	  is	  
lung	  surfactant	   (LS)	   (6-­‐13),	  a	  protein/lipid	  complex	   lining	   the	  air-­‐liquid	   interface	   in	  alveoli,	  which	  
allows	   breathing	   and	   facilitates	   gas	   exchange.	   LS	   composition	   is	   conserved	   in	   a	   fair	   number	   of	  
mammalian	  species	  (14-­‐16)	  and	  comprises	  90%	  by	  weight	  of	  lipids	  and	  8-­‐10%	  proteins.	  From	  the	  
lipid	   fraction,	   phospholipids	   are	   the	   most	   abundant	   components.	   Among	   them,	  
phosphatidylcholine	   (PC),	   phosphatidylglycerol	   (PG),	   phosphatidylinositol	   (PI),	  
phosphatidylethanolamine	  (PE),	  phosphatidylserine	  (PS)	  and	  small	  amounts	  of	  sphingolipids	  such	  
as	  sphingomyelin	  (SM)	  have	  been	  identified	  by	  TLC.	  Neutral	  lipids,	  especially	  cholesterol,	  are	  also	  
present.	  
Proteins	  co-­‐isolated	  together	  with	  LS	  complexes	  are	  typically	  in	  close	  contact	  with	  lipids,	  such	  as	  in	  
the	  case	  of	  surfactant	  protein	  A	  (SP-­‐A)	  (17),	  whereas	  other	  soluble,	  non-­‐lipid	  interacting,	  proteins	  
present	  in	  the	  bronchoalveolar	  lavage	  (18)	  are	  lost	  during	  LS	  purification	  (19).	  
The	   so-­‐called	   surfactant-­‐associated	   proteins,	   SP-­‐A,	   SP-­‐B,	   SP-­‐C	   and	   SP-­‐D,	   have	   been	   traditionally	  
studied	   after	   their	   separation	   from	   its	   native	   lipid	   context	   by	   means	   of	   electrophoresis	   and	  
western	  blot	   (WB).	  However,	  due	  to	   the	  high	   lipid	  content	   in	  bronchoalveolar	   lavage	  or	   isolated	  
surfactant,	   electrophoresis	   and	   blotting	   often	   results	   in	   deformed	   protein	   bands	   and	   poor	  
detection.	  Moreover,	  small	  fractions	  of	  strongly	  interacting	  lipids	  are	  usually	  co-­‐isolated	  with	  the	  
hydrophobic	  proteins	  of	  surfactant,	  SP-­‐B	  and	  SP-­‐C,	  making	  their	  study	  by	  WB	  a	  difficult	  task.	  	  
Here,	   we	   present	   a	   methodology	   that	   overcomes	   those	   difficulties	   by	   combining	   TLC	   and	  
electrophoresis	  to	  qualitatively	  study	  the	  lipid	  and	  protein	  fingerprint	  of	  whole	  native	  surfactants	  
or	  other	  native	  membrane	  complexes.	  Lipid	  characterization	  by	  TLC	  typically	  includes	  the	  organic	  
extraction	  of	  the	  lipid	  component	  from	  a	  given	  biological	  sample.	  Extracted	  samples	  solubilized	  in	  
organic	   solvents	   are	   then	   directly	   applied	   on	   the	   TLC	   silica	   plates,	   avoiding	   water-­‐soluble	  
“contaminants”	   such	   as	   proteins.	  We	  propose	   an	   alternative	  method	   that	   preserves	   polar	   lipid-­‐
protein	  interactions	  and	  allows	  the	  simultaneous	  lipid/protein	  characterization	  of	  LS	  samples	  and	  
other	  membrane	  complexes.	  An	  example	  of	  application	  to	  the	  study	  of	  protein/lipid	   interactions	  
of	  small	  membrane	  proteins	  is	  also	  presented.	  	  
	  
	   	  
















MATERIALS	  AND	  METHODS	  
All	  phospholipid	  standards	  were	  purchased	   from	  Avanti	  Polar	  Lipids	   (Alabama,	  USA)	  and	  organic	  
solvents	   were	   HPLC	   grade	   from	   LabScan	   (Gliwice,	   Poland).	   The	   N-­‐terminal	   peptide	   from	  
endothelial	   Nitric	   Oxide	   Synthase	   (eNOS)	   was	   provided	   by	   Dr.	   Ignacio	   Rodriguez-­‐Crespo,	   from	  
Complutense	  University	   in	  Madrid,	  and	  bacteriorhodopsin	  was	  a	  kind	  gift	  of	  Prof.	  Esteve	  Padros,	  
from	   Autonomous	   University	   of	   Barcelona.	   Surfactant	   protein	   SP-­‐C	   was	   isolated	   from	   porcine	  
lungs	   as	   described	   (20).	   	   SP-­‐C	   and	   SP-­‐B	   analogues	   (KL4:	   KLLLLKLLLLKLLLLKLLLLK;	   KL2A2:	  
KLAALKLAALKLAALKLAALK;	   KL4PQ:	   KLLLLKLLLLPQLLLLKLLLLK)	   were	   synthesized	   by	   F-­‐moc	   matrix-­‐
assisted	   chemistry	   at	   the	   laboratory	   of	   Prof.	   David	   Andreu,	   from	   Pompeu	   Fabra	   University	   in	  
Barcelona.	  Protein	  stocks	  were	  prepared	  as	  follows:	  eNOS	  (1mg/ml)	  in	  methanol,	  SP-­‐C	  and	  SP-­‐B	  (1	  
mg/ml)	   in	   chloroform:	  methanol	   2:1	   v/v.	   Native	   SP-­‐C	   and	   bacteriorhodopsin	  were	   preserved	   as	  
isolated.	   Lipid	   stocks	   were	   prepared	   and	   stored	   at	   the	   desired	   concentrations	   in	  
chloroform/methanol	  (2:1	  v/v).	  
	  
Isolation	  of	  porcine	  lung	  surfactant	  
Native	   porcine	   lung	   surfactant	  was	   purified	   from	   bronchoalveolar	   lavage	   (BAL)	   by	   NaBr	   density	  
gradient	  as	  previously	  described	  (21).	  Briefly,	  BAL	  was	  obtained	  by	  introducing	  and	  recovering	  ice	  
cold	  Tris	  5mM	  in	  0.9%	  NaCl	   into	  the	  trachea	  of	  porcine	   lungs	  obtained	  from	  the	  slaughterhouse.	  
BALs	  were	  gauze-­‐filtered	  and	  centrifuged	  to	  remove	  cells	  and	  debris.	  Supernatant	  containing	  cell-­‐
depleted	  BALs	  were	  collected	  and	  stored	  at	  -­‐20°C	  until	  use.	  To	  obtain	  the	  full	  membrane	  fraction,	  
samples	  were	  thawed	  and	  centrifuged	  at	  100.000	  g,	  4°C	  for	  1h	  (70	  Ti	  fixed-­‐angle	  rotor,	  Beckman	  
Coulter).	  Pellets	  were	  resuspended	  in	  NaBr	  16%	  NaCl	  0.9%	  and	  pooled.	  This	  fraction	  was	  placed	  at	  
the	  bottom	  of	  a	  centrifuge	   tube,	  onto	  which	   two	   less	  dense	  solutions,	  NaBr	  13%	  NaCl	  0.9%	  and	  
NaCl	   0.9%,	   were	   carefully	   deposited.	   Samples	   in	   this	   discontinuous	   density	   gradient	   were	  
centrifuged	  at	  120.000xg,	  4°C	  for	  2h	  (SW40	  Ti	  swinging-­‐bucket	  rotor,	  Beckman	  Coulter).	  Surfactant	  
complexes,	  comprising	  phospholipids	  and	  associated	  proteins,	   formed	  a	  compact	   layer	  on	  top	  of	  
the	   NaBr	   13%	   NaCl	   0.9%	   solution.	   Samples	   were	   carefully	   recovered	   avoiding	   the	   collection	   of	  
NaBr	   13%	  NaCl	   0.9%	   solution,	   further	   diluted	   in	   NaCl	   0.9%	   and	   flash	   frozen	   in	   liquid	   N2.	   These	  
samples	  are	  termed	  native	  surfactant	  (NS).	  
Organic	  extraction	  of	  lung	  surfactant	  
For	  LS	  organic	  extraction,	  the	  protocol	  of	  Bligh	  and	  Dyer	  was	  followed	  (22).	  Briefly,	  samples	  were	  
mixed	  with	  methanol	  and	  chloroform	  in	  a	  1:2:1	  volumetric	  ratio	  and	  vigorously	  mixed	  for	  30sec.	  
Soluble	   proteins	   were	   flocculated	   by	   30	   min	   incubation	   at	   37°C.	   Addition	   of	   one	   volume	   of	  
chloroform	   and	   one	   volume	   of	   water	   resulted	   in	   the	   formation	   of	   two	   phases	   that	   were	   fully	  
separated	   by	   centrifugation	   (2.000xg,	   5min,	   4°C).	   The	   organic	   (bottom)	   phase	   was	   collected	  
whereas	  the	  aqueous	  (top)	  phase	  was	  subjected	  to	  two	  consecutive	  extraction	  steps	  yielding	  the	  
maximum	   phospholipid	   extraction.	   Organic	   phases	   were	   then	   pooled	   and	   stored	   at	   -­‐20°C	   in	  
borosilicate	  tubes.	  These	  samples	  are	  termed	  organic	  extracts	  (OE).	  
	  
Lipid	  and	  lipid/protein	  sample	  preparation	  
To	  prepare	  liposome	  suspensions,	  lipids	  alone	  or	  a	  combination	  of	  lipid	  and	  hydrophobic	  proteins	  
were	  mixed	   in	   chloroform/methanol	   (2:1	   v/v)	   in	   the	  proportions	   indicated	   for	   each	  experiment.	  
Samples	   were	   dried	   out	   under	   a	   nitrogen	   stream	   and	   left	   in	   vacuum	   for	   2h	   in	   a	   SpeedVac	  
Concentrator	  System	  (Thermo	  Scientific).	  Multilamellar	  suspensions	  were	  prepared	  by	  rehydrating	  
samples	  in	  Tris	  buffer	  (5	  mM	  Tris,	  150	  mM	  NaCl	  pH	  7)	  at	  50	  °C	  for	  1	  h	  with	  intermittent	  shacking.	  
















For	  samples	  containing	  bacteriorhodopsin,	  the	  protein	  was	  added	  during	  the	  rehydration	  step.	  Per	  
sample,	  100	  μg	  of	  phospholipid	  was	  used	  to	  a	  final	  concentration	  of	  10	  mg/ml.	  	  
	  
Thin	  layer	  chromatography:	  plates	  and	  application	  of	  samples	  
Chromatoplates,	   20x20	   cm,	   pre-­‐coated	   with	   Silicagel	   60	   (ref.	   1.05748.0001,	   Merck,	   Germany)	  
were	  used	  in	  this	  study.	  Both	  samples	  and	  standards	  were	  applied	  at	  a	  phospholipid	  concentration	  
of	  10mg/ml	  as	  aqueous	  suspensions	  (10µl)	  or	  organic	  extracts	  as	  indicated.	  	  
Samples	   and	   standards	  were	   applied	   subsequently	   in	   small	   volumes	   (3-­‐5	  µl	   steps)	   using	   a	   10	  µl	  
Hamilton	  syringe	  or	  pipette	  forming	  a	   line	  at	  the	  bottom	  of	  the	  plate,	  here	  and	  thereafter	  called	  
the	  application	  point	   (AP).	   Samples	  were	  air-­‐dried	  at	   room	  temperature	  before	   the	  next	   sample	  
application.	  Once	  the	  solvent	  was	  evaporated,	  dried	  samples	  appeared	  indistinguishable	  from	  the	  
background.	  Plates	  with	  the	  applied	  samples	  were	  placed	  in	  a	  fume-­‐hood	  and	  further	  dried	  out	  at	  
room	  temperature	   for	  15-­‐20	  min.	  The	  developing	  solvent	  system	  used	   in	   these	  TLC	  experiments	  
was	   chloroform/methanol/water	   65:25:4	   (v/v/v).	   The	   chromatographic	   chamber	  
(Shandon	  Scientific	  Co.	  Ltd,	  UK)	  was	  lined	  on	  three	  sides	  with	  Whatman	  No.	  1	  filter	  paper	  wetted	  
with	   the	   developing	   solvent	   system.	   The	   chamber	  was	   saturated	  with	   fresh	   solvent	   for	   30	  min	  
before	  running	  the	  chromatography.	  Thereafter,	  the	  developed	  plate	  was	  removed	  and	  air-­‐dried	  
completely	  before	  staining.	  	  	  
For	   the	   detection	   of	   lipids,	   the	   plate	  was	   placed	   vertically	   in	   a	   second	   chamber	   saturated	  with	  
iodine	   vapour	   (Sigma	  Aldrich,	  Missouri,	  USA).	   Iodine	  binds	   to	  unsaturated	   carbon	  bonds	  of	   lipid	  
molecules	  resulting	  in	  dark	  bands	  along	  the	  TLC	  plate.	  	  
A	  fluorescamine	  solution	  (Sigma	  Aldrich,	  MO)	  0.5%	  in	  acetone	  was	  sprayed	  on	  the	  plate	  in	  order	  to	  
detect	  primary	  amine-­‐free	  containing	  molecules	   (23),	   such	  as	  amine-­‐containing	  phospholipids	  or	  
proteins	   in	   our	   case.	   The	   detection	   of	   fluorescence	   is	   possible	   under	   UV	   light.	   Images	   were	  
recorded	  using	  a	  VersaDoc	  imaging	  system	  (Biorad,	  Hercules,	  CA)	  in	  the	  epifluorescence	  mode.	  For	  
the	  visualization	  of	  both	   lipids	   and	  proteins	   in	   the	   sample	  plate,	   fluorescamine	  was	  applied	  and	  
the	  images	  were	  recorded	  before	  iodine	  staining	  to	  avoid	  fluorescence	  quenching	  by	  iodine	  vapor.	  	  
SDS-­‐PAGE	  
TLC	   bands	   were	   scratched	   out	   and	   boiled	   at	   99°C	   for	   10	   min	   in	   a	   Thermomixer	   (Eppendorf,	  
Hamburg,	  DE)	  after	  the	  addition	  of	  electrophoresis	  Laemmli	  buffer	  (2%	  SDS,	  62.5	  mM	  Tris	  pH	  6.8,	  
10%	  glycerol,	  0.03%	  bromophenol	  blue)	  containing	  4%	  β-­‐mercaptoethanol.	  Before	  application	  into	  
the	   electrophoresis	   gels,	   samples	  were	   spin	   down	   pelleting	  most	   of	   the	   silicagel.	   Samples	  were	  
applied	   either	   into	   13%	   or	   Mini-­‐protean	   precast	   gradient	   polyacrylamide	   gels	   (4-­‐16%,	   BioRad,	  
Hercules,	   CA)	   and	   electrophoresis	   were	   performed	   in	   a	   Mini-­‐protean	   BioRad	   system	   (BioRad,	  
Hercules,	  CA).	  Visualization	  of	  the	  bands	  was	  achieved	  by	  silver	  staining.	  
Identification	  of	  proteins:	  Western	  Blot	  and	  mass	  spectrometry	  
The	  analysis	  of	  the	  protein	  content	  was	  assessed	  by	  Western	  Blot.	  Proteins	  were	  transferred	  onto	  
PVDF	  membranes	  with	  a	  semi-­‐dry	  system	  (BioRad)	  for	  1h	  at	  2.3mA/cm2	  membrane	  and	  blocked	  in	  
PBS–T	   (100mM	   Na2HPO4/KH2PO4-­‐	   1%	   Tween)	   5%	   skimmed	   milk	   at	   room	   temperature	   for	   2h.	  
Membranes	  were	   then	   incubated	  overnight	  with	   the	  primary	   antibody	   in	   PBS-­‐T	   5%	  milk	   at	   4°C,	  
washed	   thoroughly	   in	   PBS-­‐T	   and	   incubated	   with	   the	   secondary	   antibody	   for	   2h	   at	   room	  
temperature.	  Before	  development,	  membranes	  were	  further	  washed,	  and	  then	  developed	  using	  a	  
commercial	  ECL	   system	   (Millipore,	  MA).	  Primary	  antibodies	  used	  were:	  anti-­‐SP-­‐A	   (1:2000)	  kindly	  
provided	   by	   Prof.	   Joe	   Wright,	   anti-­‐SP-­‐B	   (1:2000)	   from	   Seven	   Hills	   (WRAB-­‐48604),	   anti-­‐SP-­‐C	  
















(1:2500)	  from	  Seven	  Hills	  (WRAB-­‐76694).	  Secondary	  antibody	  (1:5000)	  used	  in	  all	  cases	  was	  anti-­‐
rabbit	  (P0217)	  from	  Dako.	  
Bands	  from	  silver	  stained	  gels	  were	  analysed	  at	  the	  proteomic	  facility	  in	  CNB-­‐CSIC	  (Madrid,	  Spain)	  
using	  Peptide	  Mass	  Fingerprinting	  MS	  -­‐	  MS/MS	  by	  MALDI	  TOF/TOF.	  
	   	  

















The	  lipid	  bands	  resolved	  in	  a	  TLC	  of	  a	  native	  surfactant	  sample	  applied	  as	  aqueous	  suspension	  (NS)	  
or	   as	   organic	   extracted	   surfactant	   in	   organic	   solvent	   (OE)	   did	   not	   substantially	   differ,	   and	  
comprised	  mainly	  phosphatidylcholine	  (PC),	  phosphatidylglycerol	  (PG),	  phosphatidylethanolamine	  
(PE),	  sphingomyelin	  (SM)	  and	  neutral	  lipids	  (NL)	  (Fig.	  1).	   	  Interestingly,	  the	  main	  difference	  in	  the	  
band	   pattern	   when	   comparing	   surfactant	   in	   aqueous	   and	   organic	   solvent	   solution	   lied	   in	   the	  
application	   point	   (AP).	   Phospholipids	   were	   not	   detected	   at	   the	   AP	   after	   organic	   phosphorous	  
detection	   (data	   not	   shown).	   However,	   hydrophilic	   components	   of	   surfactant,	   such	   as	   soluble	  
proteins,	   were	   expected	   to	   stay	   at	   the	   AP.	   To	   analyse	   the	   protein	   content,	   AP	   bands	   were	  
scratched	  out	  and	  subjected	  to	  SDS-­‐PAGE	  and	  silver	  staining	  (Fig.	  2).	  	  
A	  number	  of	  protein	  bands	  were	  visible	  in	  the	  AP	  of	  native	  surfactant	  samples	  (Fig.	  2A).	  As	  it	  could	  
be	  anticipated,	  those	  proteins	  were	  also	  detectable	  in	  BAL	  fluid	  in	  larger	  amounts,	  whereas	  many	  
other	  proteins	  observed	  in	  BAL	  were	  absent	  in	  NS	  samples	  (Fig.	  2B).	  Therefore,	  only	  proteins	  with	  
a	  significant	  interaction	  with	  lung	  surfactant	  are	  co-­‐isolated	  with	  it	  and	  hence,	  the	  protein	  bands	  
identified	  in	  the	  AP	  NS	  represented	  specific	  surfactant-­‐associated	  proteins.	  Among	  them,	  SP-­‐A,	  SP-­‐
B	  and	  SP-­‐C	  could	  be	  identified	  by	  western	  blot	  (Fig.	  2C).	  Mass	  spectrometry	  analysis	  revealed	  that	  
proteins	  appearing	  at	  the	  AP	  in	  NS	  were	  not	  classical	  surfactant-­‐associated	  proteins	  but	  involved	  in	  
the	  immune	  response	  (IgM,	  IgA),	  characteristic	  of	  blood	  (albumin,	  hemoglobin,	  serotransferrin)	  or	  
tissue	  (beta-­‐actin)	  (Supp.	  Fig.	  1).	  
SP-­‐A,	   the	  main	  hydrophilic	   surfactant	  protein,	  was	  only	   found	   in	  NS	  and	  not	   in	  OE	  as	   expected,	  
whereas	  SP-­‐B	  was	  present	  in	  both	  AP	  of	  NS	  and	  OE.	  SP-­‐C,	  however,	  did	  not	  appear	  at	  the	  AP	  when	  
samples	  were	  applied	  as	  aqueous	  solution	  but	  rather	  run	  together	  with	  PC.	  To	  confirm	  this	  special	  
behaviour,	   PC	   liposomes	   containing	   increasing	   amounts	   of	   SP-­‐C	   were	   also	   applied	   as	   aqueous	  
solutions	  and	  analysed	  by	   this	  method.	  As	  observed	   in	  Fig.	  2D,	  SP-­‐C	  configured	  a	  different	  band	  
below	  that	  of	  PC.	  Higher	  SP-­‐C	  content	  resulted	  in	  an	  increase	  in	  the	  fluorescamine-­‐stain	  intensity,	  
confirming	  the	  presence	  of	  the	  protein	  in	  those	  particular	  bands.	  These	  findings	  suggest	  that	  some	  
native	  SP-­‐C-­‐lipid	  interactions	  might	  still	  be	  preserved	  even	  under	  the	  presence	  of	  organic	  solvents	  
in	  the	  developing	  phase	  of	  the	  TLC.	  Upon	  organic	  extraction	  this	  interaction	  no	  longer	  remained,	  
as	  deduced	  from	  the	  presence	  of	  lipid-­‐free	  SP-­‐C	  at	  the	  AP	  when	  organic	  extracted	  surfactant	  was	  
analysed.	  
To	   further	   analyse	  whether	   SP-­‐C	   behaviour	  was	   shared	   by	   any	   other	   small	  membrane	   proteins,	  
different	   proteins	   and	   peptides	  were	   reconstituted	   into	   PC	  membranes	   and	   tested	   (Fig.	   3).	   The	  
palmitoylated	   N-­‐terminal	   fragment	   of	   the	   enzyme	   eNOS	   behaved	   similarly	   to	   SP-­‐C	   (Fig.	   3A),	  
revealing	   that	   protein-­‐lipid	   interactions	   non-­‐specific	   to	   SP-­‐C	   might	   be	   responsible	   for	   this	  
migration	  pattern.	  However,	  a	  membrane	  protein	  of	  a	  larger	  size,	  such	  as	  bacteriorhodopsin,	  does	  
not	   migrate	   out	   of	   the	   application	   point	   of	   the	   TLC	   under	   these	   conditions,	   in	   spite	   that	   its	  
sequence	  is	  little	  more	  than	  7	  transmembrane	  helices.	  Small	  synthetic	  peptides	  used	  as	  potential	  
surrogates	  of	  surfactant	  proteins	  in	  the	  design	  of	  synthetic	  surfactant	  clinical	  preparations,	  such	  as	  
KL4	  or	  KL2A2,	  were	  also	  able	  to	  run	  along	  the	  TLC	  plate	  (Fig.	  3B)	  not	  only	  associated	  to	  PC	  species	  
but	   also	   to	  PG	   (such	  as	  KL4PQ).	   	  Again,	   this	   behaviour	  was	  only	  detectable	  when	   samples	  were	  
applied	   as	   aqueous	   suspensions,	   as	   none	   of	   the	   proteins	   analysed	   migrated	   through	   the	   plate	  
when	  they	  were	  applied	  in	  organic	  solvent	  (Fig	  3).	  	  
	  

















In	   this	  work	  we	  have	   shown	  a	  new	  application	   for	  a	   rather	   classical	   technique,	  TLC.	  The	  
main	  novelty	  relies	  on	  the	  application	  of	  native-­‐like	   lipid/protein	  samples	   in	  aqueous	  suspension	  
instead	  of	   in	  organic	  solvents.	  Thus,	   sample	  composition	   is	   fully	   retained	  as	  well	  as	  many	  of	   the	  
molecular	  polar	  and	  hydrophobic	  interactions	  especially	  relevant	  in	  the	  context	  of	  membranes	  	  
The	  added	  value	  provided	  by	  sample	  analysis	  using	  this	  methodology	  is	  illustrated	  by	  the	  
behaviour	   of	   SP-­‐C,	   which	   showed	   a	   differential	   TLC	   migration	   pattern	   compared	   with	   other	  
proteins	   and	   lipids.	   SP-­‐C	   is	   dually	   palmitoylated	   (24),	   and	   because	   of	   its	   extremely	   hydrophobic	  
character,	   its	  migration	   pattern	   through	   the	   TLC	   plate	   could	   be	   interpreted	   as	   SP-­‐C	   adopting	   a	  
lipid-­‐like	  configuration.	  However,	  given	  that	  SP-­‐C	  only	  migrated	  when	  the	  protein	  was	  applied	  as	  
part	   of	   lipid/protein	   complexes	   in	   aqueous	   solutions,	   SP-­‐C	   hydrophobicity	   is	   not	   sufficient	   to	  
explain	   this	   behaviour.	   Strong	   SP-­‐C/phospholipid	   interactions	   might	   then	   be	   likely	   preserved,	  
possibly	   involving	   some	   solvation	  water	  molecules.	   The	   confirmation	   of	   a	   similar	   behaviour	   for	  
other	   small	   membrane-­‐associated	   proteins	   such	   as	   the	   eNOS	   N-­‐terminal	   sequence	   or	   the	  
surfactant	  peptide	  analogues	  KL4,	  KL4PQ	  and	  KL2A2,	  further	  supports	  that	  this	  migration	  pattern	  
is	   due	   to	   the	   preservation	   of	   native	   protein-­‐lipid	   interactions.	   Interaction	   with	   different	  
(phospho)lipids	   and	   protein/lipid	   ratio	   are	   relevant	   factors	   to	   consider	   when	   analysing	   specific	  
protein/lipid	  interactions.	  In	  the	  case	  of	  SP-­‐C,	  its	  migrating	  behaviour	  was	  observed	  from	  small	  to	  
large	  amounts	  until	  10%	  by	  weight,	  suggesting	  that	  up	  to	  10	  wt%,	  SP-­‐C/lipid	   interactions	  are	  not	  
saturated.	  However,	  this	  cannot	  be	  extrapolated	  to	  other	  membrane	  proteins,	  for	  which	  the	  role	  
of	  different	  protein/lipid	  ratios	  and	  particular	  lipid	  species	  remain	  to	  be	  investigated.	  
Depending	   on	   their	   polarity,	   samples	   components	   partition	   between	   the	   hydrophobic	  
(solvent)	   mobile	   and	   polar	   (silica)	   phases.	   For	   this	   reason,	   lipids	   are	   carried	   by	   the	   developing	  
phase	  whereas	  most	  proteins	  remain	  delipidized	  at	  the	  AP.	  Upon	  application	  as	  aqueous	  solutions,	  
tight	   protein/lipid/water	   complexes	  withstanding	  organic	   solvent	   solubilization	   could	   allow	   their	  
migration	   as	   a	   unit	   along	   the	   TLC	   plate,	   thus	   opening	   the	   possibility	   for	   studying	   functional	  
lipid/lipid	  and	  lipid/protein	  interactions	  in	  native	  cell	  membranes.	  	  	  	  	  	  	  
	  	  	  	  	  	   The	   behaviour	   of	   the	   protein	   examples	   analysed	   here	   suggests	   that	   for	   a	   protein	   to	  
migrate	   associated	   with	   lipids	   in	   a	   “native”	   TLC	   it	   needs	   to	   have	   a	   dominant	   hydrophobic	  
character,	  so	  that	  an	   important	  fraction	  of	   its	  structure	  could	  be	  mobilized	  while	  exposed	  to	  the	  
organic	  mobile	  phase.	  In	  the	  case	  of	  SP-­‐C,	  its	  α-­‐helix	  as	  well	  as	  its	  palmitoylated	  cysteines	  are	  likely	  
fully	  exposed	  to	  the	  organic	  solvent,	  whereas	  the	  charged	  N-­‐terminal	  segment	  of	  the	  protein	  could	  
preserve	  the	  interaction	  with	  some	  phospholipid	  headgroups	  thanks	  to	  remaining	  solvation	  water	  
molecules.	   Other	   small	   amphipathic	   proteins	   and	   peptides	   could	   adopt	   a	   similar	   configuration.	  
However,	   for	   a	   protein	   such	   as	   bacteriorhodopsin,	   with	   polar	   groups	   at	   the	   two	   sides	   of	   the	  
membranes,	  such	  an	  orientation	  towards	  the	  organic	  solvent	  would	  be	  incompatible	  hindering	  its	  
development	  through	  the	  plate.	  Whether	  a	  few	  specific	  lipid	  molecules	  are	  retained	  by	  these	  AP-­‐
immobilized	  proteins	  warrants	  further	  investigation.	  
	  	  	  	  	  	   The	   methodology	   presented	   here	   also	   allows	   to	   study	   the	   hydrophilic	   component	   of	   a	  
sample	   such	   as	   surfactant	   considering	   those	   soluble	   proteins	   strongly	   associated	   to	  
membrane/surfactant	  complexes.	  This	  protein	  fingerprinting	  could	  be	  useful	  not	  only	  for	  assessing	  
the	  purity	  and	  quality	  of	  clinical	  surfactant	  preparations,	  but	  also	  to	  understand	  and	  diagnose	  lung	  
diseases.	  For	   instance,	   the	   identification	  of	  albumin	   in	   surfactant	   samples	  might	  be	   indicative	  of	  
edema	  and	   fluid	   leaking	   into	   the	   alveolar	   spaces,	   indicating	  ARDS	   risk	  or	   different	   stages	  of	   the	  
















disease	  (25,	  26).	  Other	  potential	  molecular	  markers	  identified	  in	  this	  work	  are	  haemoglobin,	  which	  
is	  over-­‐expressed	  in	  the	  lung	  under	  hypoxic	  conditions	  (19,	  27),	  and	  IgM	  and	  IgA,	  whose	  increase	  is	  
linked	  to	  different	  interstitial	  lung	  diseases	  such	  as	  sarcoidosis	  (28),	  idiopathic	  pulmonary	  fibrosis	  
or	  chronic	  hypersensitivity	  pneumonitis	   (29).	  Beta	  actin	  might	  also	  be	  considered	  as	  a	  marker	  of	  
cell	   damage	   related	   to	   lung	   disease	  whereas	   serotransferrin	   levels	   could	   be	   a	   good	   indicator	   of	  
redox	  activity	  as	  detected	  under	  the	  exposure	  to	  cigarrete	  smoke	  (30,	  31),	  NO2	  (32),	  O3	  (33,	  34),	  	  
hyperoxia	  (35,	  36)	  or	  hypoxia	  (19,	  37).	  	  
Taken	   together,	   our	   findings	   support	   that	   this	   novel	   application	   of	   TLC	   represents	   a	  
promising	   tool	   to	   analyse	   and	   identify	   native	   protein/lipid	   interactions	   not	   only	   restricted	   to	  
surfactant	  samples.	  Additionally,	  protein/lipid	  fingerprinting	  of	  surfactant	  samples	   from	  patients,	  
animal	   models	   or	   surfactant	   clinical	   preparations,	   may	   contribute	   to	   the	   understanding	   and	  
diagnosis	  of	  lung	  diseases.	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Thin	  layer	  chromatography	  of	  surfactant	  in	  aqueous	  solution	  (NS)	  and	  in	  organic	  solvent	  (OE)	  	  
Samples	   applied	   include	   aqueous	   suspensions	   of	   native	   surfactant	   purified	   from	   porcine	  
bronchoalveolar	   lavage	   (NS)	   and	   its	   organic	   extract	   applied	   as	   a	   chloroform/methanol	   solution	  
(OE).	   Applied	   lipid	   standards	   include:	   phosphatidylcholine	   (PC),	   phosphatidylethanolamine	   (PE),	  
phosphatidylglycerol	  (PG),	  phosphatidylinositol	  (PI),	  phosphatidylserine	  (PS),	  sphingomyelin	  (SM),	  
lysophosphatidylcholine	  (LPC),	  and	  cholesterol	  (Chol).	  Bands	  stained	  with	  iodine	  revealed	  SM,	  PC,	  
PG,	  PE,	  NL	  (neutral	  lipids,	  including	  cholesterol)	  and	  the	  AP	  (application	  point)	  band	  where	  water-­‐































Electrophoretic	   analysis	   of	   proteins	   associated	  with	   surfactant	   samples	   as	   extracted	   from	   TLC	  
plates	  
Panel	   A,	   silver	   staining	   of	   a	   PAGE-­‐SDS	   performed	   with	   the	   material	   scrapped	   from	   the	   AP	  
(application	   point)	   and	   the	   PC	   (phosphatidylcholine)	   TLC-­‐bands	   from	   NS	   or	   OE.	   Panel	   B,	   silver	  
stained	  gel	  of	  the	  AP	  of	  BAL	  and	  NS	  after	  TLC.	  Equivalent	  amounts	  of	  phospholipid	  were	  applied	  
(100	  µg).	  Panel	  C,	   immunodetection	  of	   surfactant	  associated	  proteins	   in	   the	  AP	  and	  PC	   lanes	  by	  
western	  blot.	  Panel	  D,	  iodine-­‐stained	  (upper	  panel)	  and	  fluorescamine-­‐stained	  (lower	  panel)	  TLC	  of	  
lipid/protein	   samples	   incorporating	   different	   amounts	   of	   SP-­‐C	   expressed	   in	   %	   by	   weight	   and	  
applied	   as	   aqueous	   suspensions	   onto	   the	   TLC	   plate.	   Arrows	   indicate	   the	   position	   of	   the	   band	  


































TLC	  analysis	  of	  different	  lipid/protein	  complexes	  applied	  as	  aqueous	  suspensions.	  	  
A:	  left	  panel,	  iodine-­‐developed	  TLC	  plate	  of	  lipid	  or	  lipid/protein	  membrane	  complexes	  applied	  as	  
aqueous	  solution	  of	  PC,	  PC/eNOS	  N-­‐terminal	  segment,	  and	  PC/BR	  (bacteriorhodopsin);	  right	  panel,	  
fluorescamine-­‐developed	   TLC	   plate	   revealing	   the	   corresponding	   protein	   bands.	   B:	   left	   panel,	  
iodine-­‐developed	   TLC	   of	   lipid/protein	  membrane	   complexes	   applied	   as	   aqueous	   suspensions	   of	  
DPPC:POPC:POPG	  membranes	  bearing	  peptides	  KL4,	  KL4PQ	  	  or	  KL2A2.	  Right	  panel,	  fluorescamine	  
developed	   TLC	  plate	   revealing	   the	   corresponding	  peptide	  bands.	  C:	   left	   panel,	   iodine-­‐developed	  
TLC	   plate	   of	   different	   protein	   or	   peptide	   (SP-­‐C,	   eNOS,	   BR,	   KL4,	   KL4PQ,	   KL2A2)	   or	   lipid	   (POPC)	  
applied	   as	   in	   organic	   solvent;	   right	   panel,	   fluorescamine-­‐developed	   TLC	   plate	   revealing	   the	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